GlassScriptPhysician profile
Keith B Danckaert
NPI 1497787659
$2,426.05
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $888 · 2021: $503 · 2022: $15.28.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $460.50 | 2019-2022 | |
| Janssen Biotech, INC. | $357.00 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $334.56 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $219.67 | 2019-2021 | |
| Lilly USA, LLC | $186.86 | 2019-2021 | |
| Genzyme Corporation | $139.11 | 2020-2021 | |
| Amgen INC. | $138.65 | 2019-2021 | |
| Pfizer INC. | $136.82 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $105.00 | 2019-2021 | |
| Leo Pharma INC. | $62.36 | 2020-2021 | |
| Ucb, INC. | $39.86 | 2019 | |
| Almirall LLC | $39.08 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $36.17 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $25.95 | 2019-2020 | |
| Genentech USA, INC. | $23.64 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $21.39 | 2020 | |
| Dermira, INC. | $21.19 | 2019 | |
| Organogenesis INC. | $19.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.17 | 2019 | |
| Dusa Pharmaceuticals, INC. | $15.97 | 2019 | |
| Galderma Laboratories, L.P. | $15.06 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $11.29 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Danckaert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.